Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 476361 - 476380 out of 485292 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AF08) ritlecitinib (adm: O) | LITFULO 50MG CAP,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Alopecia Areata | Pfizer,Inc. |
| USA | (L04AF08) ritlecitinib (adm: O) | LITFULO 50MG CAP,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Alopecia Areata | Pfizer,Inc. |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA 200MG AUTO INJECTOR | 4X1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA 200MG AUTO INJECTOR | 4X1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA 200MG PREFILLED SYR | 4X1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA 200MG PREFILLED SYR | 4X1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA LYOPHILIZED (120MG/VL) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA LYOPHILIZED (120MG/VL) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA LYOPHILIZED (400MG/VL) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA LYOPHILIZED (400MG/VL) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 108MG/0.68ML INJ,SOLN,PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 108MG/0.68ML INJ,SOLN,PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300MG/20ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300MG/20ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG06) alemtuzumab (adm: P) | LEMTRADA 12MG/1.2ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenzymeCorporation |
| USA | (L04AG06) alemtuzumab (adm: P) | LEMTRADA 12MG/1.2ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenzymeCorporation |
| USA | (L04AG08) ocrelizumab (adm: P) | OCREVUS 300MG/10ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenentechUSA,Inc. |
| USA | (L04AG08) ocrelizumab (adm: P) | OCREVUS 300MG/10ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenentechUSA,Inc. |
| USA | (L04AG09) emapalumab | GAMIFANT 5MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
| USA | (L04AG09) emapalumab | GAMIFANT 5MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
Pages
